Pfizer stock slips after hours: what traders are watching ahead of Feb. 3 results
Pfizer shares slipped 0.3% to $25 in after-hours trading Monday, following a quiet regular session amid thin year-end volumes. Investors are awaiting the company’s Feb. 3 quarterly update after Pfizer last week guided 2025 revenue to about $62 billion and flagged ongoing pressure from lower COVID-product sales and patent expirations.